{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:38:21Z","timestamp":1774485501273,"version":"3.50.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Northwest A&F University","award":["E111020901"],"award-info":[{"award-number":["E111020901"]}]},{"name":"New Century Excellent Talents in University of China","award":["NCET-07-0701"],"award-info":[{"award-number":["NCET-07-0701"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1016\/j.vaccine.2010.11.045","type":"journal-article","created":{"date-parts":[[2010,11,30]],"date-time":"2010-11-30T10:50:46Z","timestamp":1291114246000},"page":"636-643","source":"Crossref","is-referenced-by-count":37,"title":["Baculovirus surface display of E envelope glycoprotein of Japanese encephalitis virus and its immunogenicity of the displayed proteins in mouse and swine models"],"prefix":"10.1016","volume":"29","author":[{"given":"Xin-Gang","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-Sheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhao-Cai","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong-Ni","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"De-Wen","family":"Tong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hung-Jen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2010.11.045_bib0005","series-title":"The togaviruses","first-page":"47","article-title":"Medical significance of togaviruses: an overview of diseases caused by togaviruses in man and in domestic and wild vertebrate animals","author":"Shope","year":"1980"},{"key":"10.1016\/j.vaccine.2010.11.045_bib0010","series-title":"Fields virology","first-page":"961","article-title":"Flaviviruses","author":"Monath","year":"1996"},{"key":"10.1016\/j.vaccine.2010.11.045_bib0015","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1128\/JVI.72.1.73-83.1998","article-title":"Phylogeny of the genus flavivirus","volume":"72","author":"Kuno","year":"1998","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2010.11.045_bib0020","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1128\/JVI.77.4.2600-2606.2003","article-title":"A functional epitope determinant on domain III of the Japanese encephalitis virus envelope protein interacted with neutralizing-antibody combining site","volume":"77","author":"Lin","year":"2003","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2010.11.045_bib0025","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1056\/NEJM198809083191004","article-title":"Protection against Japanese encephalitis by inactivated vaccines","volume":"319","author":"Hoke","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2010.11.045_bib0030","doi-asserted-by":"crossref","first-page":"214","DOI":"10.4269\/ajtmh.1988.39.214","article-title":"Safety of a live-attenuated Japanese encephalitis virus vaccine (SA14-14-2) for children","volume":"39","author":"Xin","year":"1988","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2010.11.045_bib0035","series-title":"Vaccines","first-page":"672","article-title":"Japanese encephalitis vaccines","author":"Tsai","year":"1999"},{"key":"10.1016\/j.vaccine.2010.11.045_bib0040","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1056\/NEJM198809083191004","article-title":"Protection against Japanese encephalitis by inactivated vaccines","volume":"319","author":"Hoke","year":"1988","journal-title":"New Engl J Med"},{"key":"10.1016\/j.vaccine.2010.11.045_bib0045","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/S0140-6736(96)91075-2","article-title":"Effectiveness of live-attenuated Japanese encephalitis vaccine [SA14-14-2]: a case\u2013control study","volume":"347","author":"Hennessey","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2010.11.045_bib0050","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0163-4453(96)91281-5","article-title":"Adverse reactions to Japanese encephalitis vaccine in travellers","volume":"32","author":"Nothdurft","year":"1996","journal-title":"J Infect"},{"key":"10.1016\/j.vaccine.2010.11.045_bib0055","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1093\/infdis\/161.5.878","article-title":"Evaluation of the potency and safety of inactivated Japanese encephalitis vaccine in US inhabitants","volume":"161","author":"Poland","year":"1990","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2010.11.045_bib0060","first-page":"25","article-title":"Neutralizing antibody responses to Japanese encephalitis vaccine in children","volume":"26","author":"Juang","year":"1983","journal-title":"Biken J"},{"key":"10.1016\/j.vaccine.2010.11.045_bib0065","doi-asserted-by":"crossref","first-page":"4607","DOI":"10.1128\/JVI.70.7.4607-4616.1996","article-title":"The GP64 envelope fusion protein is an essential baculovirus protein required for cell-to-cell transmission of infection","volume":"70","author":"Monsma","year":"1996","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2010.11.045_bib0070","doi-asserted-by":"crossref","first-page":"3639","DOI":"10.1128\/JVI.79.6.3639-3652.2005","article-title":"Ligand directed gene targeting to mammalian cells by pseudotype baculoviruses","volume":"79","author":"Kitagawa","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2010.11.045_bib0075","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1006\/viro.1998.9523","article-title":"Requirement for GP64 to drive efficient budding of Autographa californica multicapsid nucleopolyhedrovirus","volume":"254","author":"Oomens","year":"1999","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2010.11.045_bib0080","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1038\/mt.sj.6300131","article-title":"Avian influenza virus hemagglutinin display on baculovirus envelope: cytoplasmic domain affects virus properties and vaccine potential","volume":"15","author":"Yang","year":"2007","journal-title":"Mol Ther"},{"key":"10.1016\/j.vaccine.2010.11.045_bib0085","first-page":"149","article-title":"Baculovirus surface display of E2 envelope glycoprotein of classical swine fever virus and immunogenicity of the displayed proteins in a mouse model","volume":"153","author":"Xu","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.11.045_bib0090","doi-asserted-by":"crossref","first-page":"6361","DOI":"10.1016\/j.vaccine.2008.09.008","article-title":"Baculovirus surface display of \u03b4C and \u03b4B proteins of avian reovirus and immunogenicity of the displayed proteins in a mouse model","volume":"26","author":"Lin","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.11.045_bib0095","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1016\/S1671-2927(08)60352-1","article-title":"Cloning and sequence analysis of the full-length genome of Japanese encephalitis virus strain SXBJ07 lsolated from swine","volume":"8","author":"Wang","year":"2009","journal-title":"Agric Sci China"},{"key":"10.1016\/j.vaccine.2010.11.045_bib0100","doi-asserted-by":"crossref","first-page":"10137","DOI":"10.1128\/JVI.73.12.10137-10145.1999","article-title":"Screening of protective antigens of Japanese Encephalitis Virus by DNA immunization: a comparative study with conventional viral vaccines","volume":"73","author":"Chen","year":"1999","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2010.11.045_bib0105","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1016\/S0264-410X(03)00042-2","article-title":"The domain III fragment of Japanese encephalitis virus envelope protein: mouse immunogenicity and liposome adjuvanticity","volume":"21","author":"Wu","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.11.045_bib0110","doi-asserted-by":"crossref","first-page":"10137","DOI":"10.1128\/JVI.73.12.10137-10145.1999","article-title":"Screening of protective antigens of Japanese encephalitis virus by DNA immunization: a comparative study with conventional viral vaccines","volume":"73","author":"Chen","year":"1999","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2010.11.045_bib0115","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1128\/JVI.45.1.124-132.1983","article-title":"Topographical analysis of antigenic determinants on envelope glycoprotein V3(E) of Japanese encephalitis virus, using monoclonal antibodies","volume":"45","author":"Kimura","year":"1983","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2010.11.045_bib0120","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0264-410X(96)00180-6","article-title":"Particulate vaccine candidate for Japanese encephalitis induces longlasting virus-specific memory T lymphocytes in mice","volume":"15","author":"Konishi","year":"1997","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.11.045_bib0125","doi-asserted-by":"crossref","first-page":"412","DOI":"10.4269\/ajtmh.1993.48.412","article-title":"Increased immunogenicity and protective efficacy in outbred and inbred mice by strategic carboxyl-terminal truncation of Japanese encephalitis virus envelope glycoprotein","volume":"48","author":"Jan","year":"1993","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2010.11.045_bib0130","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/0042-6822(92)91233-K","article-title":"A highly attenuated host range-restricted vaccinia virus strain, NYVAC, encoding the prM, E, and NS1 genes of Japanese encephalitis virus prevents JEV viremia in swine","volume":"190","author":"Konishi","year":"1992","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2010.11.045_bib0135","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1159\/000149522","article-title":"Interaction of Autographa californica nuclear polyhedrosis virus with two non-permissive cell lines","volume":"21","author":"Groner","year":"1984","journal-title":"Intervirology"},{"key":"10.1016\/j.vaccine.2010.11.045_bib0140","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0042-6822(83)90067-3","article-title":"Autographa californica nuclear polyhedrosis virus (AcNPV) DNA does not persist in mass cultures of mammalian cells","volume":"125","author":"Tjia","year":"1983","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2010.11.045_bib0145","doi-asserted-by":"crossref","first-page":"5527","DOI":"10.1128\/JVI.73.7.5527-5534.1999","article-title":"The anamnestic neutralizing antibody response is critical for protection of mice from challenge following vaccination with a plasmid encoding the Japanese encephalitis virus premembrane and envelope genes","volume":"73","author":"Konishi","year":"1999","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2010.11.045_bib0150","doi-asserted-by":"crossref","first-page":"5205","DOI":"10.1016\/j.vaccine.2005.07.002","article-title":"Report on a WHO consultation on immunological endpoints for evaluation of new Japanese encephalitis vaccines, WHO, Geneva, September 2\u20133, 2004","volume":"23","author":"Hombach","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.11.045_bib0155","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0264-410X(00)00041-4","article-title":"Immunogenicity and protective efficacy of the current inactivated Japanese encephalitis vaccine against different Japanese encephalitis virus strain","volume":"18","author":"Kurane","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.11.045_bib0160","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/0042-6822(92)91233-K","article-title":"A highly attenuated host-range restricted vaccinia virus strain, NYVAC, encoding the prM, E and NS1 genes of Japanese encephalitis virus prevents JEV viremia in swine","volume":"190","author":"Konishi","year":"1992","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2010.11.045_bib0165","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1128\/JVI.67.3.1672-1675.1993","article-title":"Proper maturation of the Japanese encephalitis virus envelope glycoprotein requires cosynthesis with the premembrane protein","volume":"67","author":"Konishi","year":"1993","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2010.11.045_bib0170","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1128\/JVI.63.6.2521-2526.1989","article-title":"Cell-associated West Nile flavivirus is covered with E1pre-M protein heterodimers which are destroyed and reorganized by proteolytic cleavage during virus release","volume":"63","author":"WenglerG","year":"1989","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2010.11.045_bib0175","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/0042-6822(91)90034-9","article-title":"Japanese encephalitis virus\u2013vaccinia recombinants produce particulate forms of the structural membrane proteins and induce high levels of protection against lethal JEV infection","volume":"180","author":"Mason","year":"1991","journal-title":"Virology"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10016798?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10016798?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,14]],"date-time":"2020-06-14T05:45:02Z","timestamp":1592113502000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X10016798"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["S0264410X10016798"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2010.11.045","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1]]}}}